Mirae Asset Global Investments Co., Ltd. Immuneering Corp Transaction History

Mirae Asset Global Investments Co., Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$4.84 - $8.44 $3,325 - $5,798	-687 Reduced 5.82%	11,118 $81,000
Q3 2023 Oct 26, 2023	BUY	$7.21 - $10.68 $187 - $277	26 Added 0.22%	11,805 $90,000
Q2 2023 Aug 10, 2023	BUY	$6.49 - $13.36 $76,445 - $157,367	11,779 New	11,779 $119,000

4.64M

Ticker IMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,392,300
Market Cap $55.4M
Description
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.